IOVA (STOCKS)
Iovance Biotherapeutics, Inc. Common Stock
$6.500400
-0.239600 (-3.55%)
Prev close: $6.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Frederick G. Vogt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,611.34M
- Employees
- 838
- P/E (TTM)
- -9.04
- P/B (TTM)
- 4.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
9
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.11 | $-0.13 | +0.0183 | +14.26% |
|
Mar 2026 (Q1)
|
$-0.19 | $-0.15 | -0.0372 | -24.35% |
|
Dec 2025 (Q4)
|
$-0.18 | $-0.18 | -0.0049 | -2.80% |
|
Sep 2025 (Q3)
|
$-0.25 | $-0.26 | +0.0132 | +5.02% |
Financial Statements
| Assets | $915.53M |
| Current Assets | $464.26M |
| Inventory | $55.59M |
| Other Current Assets | $408.67M |
| Noncurrent Assets | $451.27M |
| Fixed Assets | $131.46M |
| Other Non-current Assets | $319.81M |
| Liabilities | $179.49M |
| Current Liabilities | $106.85M |
| Accounts Payable | $26.21M |
| Other Current Liabilities | $80.64M |
| Noncurrent Liabilities | $72.64M |
| Equity | $736.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $736.05M |
| Liabilities And Equity | $915.53M |